Immunic Statistics

Total Valuation

Immunic has a market cap or net worth of $63.23 million. The enterprise value is $49.14 million.

Market Cap	63.23M
Enterprise Value	49.14M

Important Dates

The last earnings date was Thursday, May 15, 2025, after market close.

Earnings Date	May 15, 2025
Ex-Dividend Date	n/a

Share Statistics

Immunic has 95.82 million shares outstanding. The number of shares has increased by 75.28% in one year.

Current Share Class	95.82M
Shares Outstanding	95.82M
Shares Change (YoY)	+75.28%
Shares Change (QoQ)	+0.64%
Owned by Insiders (%)	1.44%
Owned by Institutions (%)	26.45%
Float	76.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.74

Current Ratio	0.74
Quick Ratio	0.56
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -246.26% and return on invested capital (ROIC) is -158.54%.

Return on Equity (ROE)	-246.26%
Return on Assets (ROA)	-101.26%
Return on Invested Capital (ROIC)	-158.54%
Return on Capital Employed (ROCE)	1,989.29%
Revenue Per Employee	n/a
Profits Per Employee	-$1.06M
Employee Count	91
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.35% in the last 52 weeks. The beta is 1.73, so Immunic's price volatility has been higher than the market average.

Beta (5Y)	1.73
52-Week Price Change	-46.35%
50-Day Moving Average	1.02
200-Day Moving Average	1.19
Relative Strength Index (RSI)	26.52
Average Volume (20 Days)	1,424,157

Short Selling Information

The latest short interest is 2.73 million, so 2.85% of the outstanding shares have been sold short.

Short Interest	2.73M
Short Previous Month	2.74M
Short % of Shares Out	2.85%
Short % of Float	3.56%
Short Ratio (days to cover)	2.18

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-101.00M
Pretax Income	-95.31M
Net Income	-96.40M
EBITDA	-100.85M
EBIT	-101.00M
Earnings Per Share (EPS)	-$0.96

Full Income Statement

Balance Sheet

The company has $14.30 million in cash and $210,000 in debt, giving a net cash position of $14.09 million or $0.15 per share.

Cash & Cash Equivalents	14.30M
Total Debt	210,000
Net Cash	14.09M
Net Cash Per Share	$0.15
Equity (Book Value)	-5.29M
Book Value Per Share	-0.06
Working Capital	-6.62M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$82.57 million and capital expenditures -$280,000, giving a free cash flow of -$82.85 million.

Operating Cash Flow	-82.57M
Capital Expenditures	-280,000
Free Cash Flow	-82.85M
FCF Per Share	-$0.86

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Immunic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-75.28%
Shareholder Yield	-75.28%
Earnings Yield	-152.45%
FCF Yield	-131.03%

Analyst Forecast

The average price target for Immunic is $11.60, which is 1,657.84% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$11.60
Price Target Difference	1,657.84%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1